Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anyone who did their DD would now that this is not surprising news. To this end, I am pleased with the communication I have received. If this news has come as a surprise to anyone, than I would recommend henceforth that you communicate with management. I am not suggesting they told me he would be resigning, but I am saying that I am not surprised.
I am too lazy to look back and see who posted the comment about the technology being key. This is true, the technology is key here. It is what has connected us, keeping us involved over the long run.
Good news is coming *soon* regarding the technical advances. Again, do your DD.
I'm aware. Just want to ensure everyone is on the rocketship that is about to take off. Back to trade season for the next couple months pre-taxes.
Can't say I didn't tell ya that our friends in Florida would be making gains next door across the hall in the laboratory.
Can't say I didn't tell ya so. Heard first hand. Its begun.
1 box, two functions. One common goal, two roller coasters. One laboratory, two to keep an eye on. One up, one down, too easy to get caught up in the story. Play the game as they have been for 3 years, and welcome $.
It's begun. Watch and see.
Word is brokers going to move BTH in coming weeks. Avg will pick up. BLO will be later in fall with trial sources say.
Don't forget, most of you have been here for 2-3 years and you're still talking about theory.
Play this stock like it should be played. Play BTH like it should be played. Shell is smart, and usually right... get cheap shares at 8 cents. Play it hard. Watch it triple. Going to be a while to see BLO triple. A long while.
Word is brokers will be picking this up. Avg traded will pick up in the coming weeks and we will see gains.
We are about to make some serious coin off this dip.
I don't judge. If investors want to play long or short who cares, more importantly, is that there is money to be made. Longs will eventually get theres. Those playing short, I would hope, realize that both companies are about to play their every-other-month pump.
Cannabix and Breathtec will pump soon. The news releases have been predictable, every few months. Cannabix will announce trials, and Breathtec will announce plans for FAIMS. My opinion is that the latter will make more money in the short term. However, I think both are going to go on a run in the near future.
Plans for Cannabix to start trials with FAIMS, suggests Breathtec is ready to do the same... it's the same device.
Watch 10 become 20 in the next few weeks.
These guys will run the stock up in the coming weeks. The time is now.
This is going to run to 20 cents shortly. Get your shares while you can. Breathtec and Cannabix are predictable. Management pumps and dumps. They let this fall as low as possible. I've been watching the accumulation take place as people foolishly let go of their cheap shares. Doubling your investment has never been so easy. Good luck to those who are in, because were about to go on our next ride.
Remember, trials are about to start with Cannabix, with the exact same technology that they are using here. Faims. Detection of compounds associated with chronic disease is an easier task than THC. So if they are having success there, it's a matter of time before they start making big moves here.
Investing 101: You have two companies, each with massive potential. One is situated around 60 cents. The other around 10 cents. The latter has a more feasible scientific task ahead of them. Both seem like winners, in due time. Volatility has been a recurring theme, with massive spikes in share price over acute time periods, with slow fade over the following months. New partnerships and cleaning house tell me that you should buy low and sell high. Anyone that is naive to this, if shown two companies side by side, would spend the 10 cents and lock and load for take off. It's just a matter of time. These companies are intertwined, for better or for worse. However, doubling 60 will take longer than doubling 10. Just watch. I'll be sure to check in after that occurs. This belongs on both boards, it's a comparison of options, my opinion on the company(s).
I respect BTH for accepting the fact that early trial results using Na-NOSE technology were sub-par and not up to the standard expected. Moving forward with FAIMS, and NOT moving forward with Na-NOSE gives me hope. Technion has world class technology, so if Breathtec would rather focus on FAIMS, maybe we can infer that management believes strongly in it.
AMG. What's your current thoughts on how things are progressing with the two companies?
So what's the latest? What are they doing here...
So what's the latest folks? Cannabix... Breathtec...
Wrong. There is no such thing as a "pre-trial". A trial is either a trial, or it is not. Them taking a device and having someone smoke weed and blow into it, off the record, means nothing. A true trial will require calibrated technology which takes into account the complex rate of degradation of active 9-THC in the blood stream, and measure at price time points following smoking to generate detection decay curves, figure out what time window the device works for, and then through all of this, tease out how the device will be able to detect active smoking from people who just have a ton of metabolites in their blood from smoking previously. This is a real time dynamic process, and pharmacodynamics matter as well. They haven't even proven the device is ready for stand alone use. This is still connected to a fridge size multi million dollar mass spectrometer.
They haven't shown any data, they haven't proven anything, in fact, they just pumped an article without showing absolutely anything, and people like you jump on it like it means something.
You, like many others, highly underestimate the difficulty of demonstrating this actually works - if it even does work...
I am holding long, this is going to take years, get real - this news means nothing.
Not going to be selling for a couple years. The length of time it will take to get to market. I am in this for the long haul. On both (BLO AND BTH).
I think BTH will reach market first.
Ok, I am find with your rationale for the share price disrepancy - it doesn't matter to me which is which (one if over priced or underpriced) because I am in long and if the price is <1 dollar I don't care.
The products are the same my friend, the technology is the exact same. EXCEPT, BTHCF has Na-NOSE, which has infinitely more value at this time than FAIMS.
And yes, you are right, different objectives. THC detection in real time will be much hard than detecting chronic disease of abundant biomarker quantity. So I guess re-iterating the fact BTHCF is undervalued.
Ok, you can disagree, but I think most people who are in this long would agree that showing trial data is going to add value, and simply posting news suggesting, hey this worked when we tried it on someone!
Both Cannabix and Breathtec will find success, but honestly this adds nothing. We have a long ways to go. They need to design and start a trial and stop convincing people like yourself that they are ahead of where they are - because there is a recent the stock dropped >20% recently. This is the save they wanted.
Pumping = news that doesn't add any value or demonstrate improvement with *evidence*
You've got it backwards. I am just one of the few people who calls it what it is. An overpriced stock that is getting pumped, with many non-scientist investors who just want to see green, calling it a success when it's not. Fact is, still not trial. Second, they've just stated that they can't detect recent use. Third point, sister company is already in trial testing with an established device and is a fraction of the price. If this isn't a pump, then show me the evidence there device is ready to go?
No doubt they pumped the share price, that's great... i'm talking about this:
They haven't proved anything. in fact they state that they cannot do it for people who just smoked:
This doesn't add anything. An an investor, they haven't added any value. Commence the trial and show results, that will add value. Currently, BLO claims to have a device, which has not been trial tested, despite being ready for testing for months. BTH has 2 devices, at least they stated when their trial will be run for FAIMS, and NA-NOSE is in trial.
My only two points are that BLO need to start the trial, and people need to recognize that this is overvalued right now (comapring to BTH which has 2 devices, one of which is in trial - that clearly highlights that people are keeping BLO share price up on hype, not on goods).
Ps: for anyone who's been here a while - this news doesn't add anything new. They said they could do this a long time ago.
Stock price has been dropping, now they are pumping again.
Funny how two companies with the same device, at the same stage in development are so different in terms of share price.
Whatever makes you happy. We are in it for the long haul, no need to get burnt out in the short term. Sustainable gains will come with Na-NOSE data from the trial and commencement of the FAIMS trial. Til' then. Hold tight.
Well said. I second this.
Have been busy lol.
Presentations, interviews, news release. This is what we like to see.
A realistic, researched timeline with accountability and transparency. This is what I am talking about!
https://www.equities.com/news/breathtecs-handheld-analysis-device-getting-within-reach-ceo-guy-latorre
One thing I like about the following article... there is a realistic, researched timeline provided. These guys are improving transparency, have the plan in place, and we know EXACTLY what's going on. Why is this relevant? Because it shows that FAIMS for breath analysis of medical compounds is on track to reach market. Hopefully we can extrapolate the same for THC detection.
https://www.equities.com/news/breathtecs-handheld-analysis-device-getting-within-reach-ceo-guy-latorre
Absolutely massive news
Massive news from the partnership over at the sister company